Try our Advanced Search for more refined results
Synthego Corporation Inter Partes Review
Case Number:
Case Type:
IPR
Status:
Final Written Decision - Appealed
Petitioner:
Synthego Corporation
Patent Owner:
Tech Center:
-
May 17, 2023
Synthego Gets PTAB To Ax 2 Agilent CRISPR Patents
The Patent Trial and Appeal Board found Wednesday that two Agilent Technologies Inc. patents on the gene-editing tool CRISPR were invalid, the latest dustup in a legal fight brought by Synthego Corp. over the breakthrough technology.
-
June 01, 2022
Synthego Gets PTAB To Review 2 Full CRISPR Patents
The Patent Trial and Appeal Board has agreed to review whether two Agilent Technologies Inc. patents related to the breakthrough gene-editing technology CRISPR should be invalidated.